EPZ015666, a selective protein arginine methyltransferase 5 (PRMT5) inhibitor with an antitumour effect in retinoblastoma
Author:
Funder
National Natural Science Foundation of China
Natural Science Foundation of Henan Province
Publisher
Elsevier BV
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference42 articles.
1. Expression of protein arginine methyltransferase-5 in oral squamous cell carcinoma and its significance in epithelial-to-mesenchymal transition;Amano;Pathol. Int.,2018
2. Overexpression of PRMT5 promotes tumor cell growth and is associated with poor disease prognosis in epithelial ovarian cancer;Bao;J. Histochem. Cytochem. : official journal of the Histochemistry Society,2013
3. Estimation of kidney function in oncology: implications for anticancer drug selection and dosing;Casal;Clin. J. Am. Soc. Nephrol. : CJASN,2019
4. A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models;Chan-Penebre;Nat. Chem. Biol.,2015
5. Role of protein arginine methyltransferase 5 in inflammation and migration of fibroblast-like synoviocytes in rheumatoid arthritis;Chen;J. Cell Mol. Med.,2017
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. PRMT1 mediates the proliferation of Y79 retinoblastoma cells by regulating the p53/p21/CDC2/cyclin B pathway;Experimental Eye Research;2024-10
2. Deficiency of betaine-homocysteine methyltransferase activates glucose-6-phosphate dehydrogenase (G6PD) by decreasing arginine methylation of G6PD in hepatocellular carcinogenesis;Science China Life Sciences;2024-04-25
3. New therapy for pancreatic cancer based on extracellular vesicles;Biomedicine & Pharmacotherapy;2023-06
4. Glioblastoma-Derived Small Extracellular Vesicles: Nanoparticles for Glioma Treatment;International Journal of Molecular Sciences;2023-03-21
5. PRMT5 is a therapeutic target in choroidal neovascularization;Scientific Reports;2023-01-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3